The initiative aims to enhance production efficiency and reduce the risk of human error-induced inconsistencies.

Fresenius Kabi will expand its drug-manufacturing operations in Wilson, potentially bringing at least 445 new jobs over five years and $100 million in investment. The German company will enlarge its ...

BIOX Bioceres Crop Solutions Corp.

Cellular Origins and Fresenius Kabi have partnered to integrate Fresenius Kabi's cell therapy processing tech with Cellular ...

An alliance with a German-based global operator promises further international expansion in the cell and gene therapies ...

On October 4, 2024, Amgen filed a BPCIA complaint in the District Court for the Northern District of Illinois Eastern Division against Fresenius ...

Genentech and Fresenius Kabi entered into a settlement ... Damage to a Baxter manufacturing facility caused by Hurricane Helene, which rolled across the east US a couple of weeks ago, has led ...

Cellular Origins and Fresenius Kabi, an operating company ... treatment while reducing development and manufacturing costs. The U.S. Food and Drug Administration (FDA) has approved flurpiridaz ...